Anticardiolipin antibodies and cardiovascular disease
The provocative article by Dr Muir (August 1995 jRSM, pp433-436) cannot go unchallenged. It ignores the existence of large international consensus groups working closely on both laboratory standardization of antiphospholipid antibodies and their isotypes and collaborative prospective treatment trials.
Muir questions the influence of a positive anticardiolipin antibodies (aCL) assay on patient management and states 'there is no therapeutic difference between patients with or without elevated aCL titre'. Although their relevance in acute stroke, venous thrombosis and cardiac disease in the general population is still debated, in the field of obstetric medicine, the presence or absence of aCL may be the single most important factor determining management strategies for the pregnant patient.
Antiphospholipid antibodies are the most frequent cause of acquired thrombophilia.
Detection therefore constitutes an indication for antenatal thromboprophylaxis with heparin in women with a history of thromboembolism 1. Furthermore, the risk of recurrent thrombosis in patients with antiphospholipid syndrome (APS) is so high (70%) that long-term anticoagulation may be needed in these patients-.
We take issue with the author's statement that 'there is no good evidence of a titrerelated risk for aCL'. Several workers have described the correlation between the titre of aCL and the risk to the fetus 3-5. Women with APS are particularly prone to second trimester loss, and controlled clinical trials support treatment with low-dose aspirin (75 mg/day) and subcutaneous heparin in preference to eorticosteroids in those with previous fetal loss6. Even in pregnancies which do not end in miscarriage, there is an increased risk of severe pre-eclampsia7, and antenatal surveillance is increased in such women.
The most persuasive evidence ignored by Muir for a cause-and-effect role for aCL comes from animal models of APS induced by passive and active immunization of rnicef ·10. Animal models have also been used to demonstrate the efficacy of low-dose aspmn in preventing pregnancy loss in experimental APS mice 11. Perhaps the more important thing to point out is the conflict that seemed to arise in the minds of many senior medical stalT. They knew that the young man had spent time getting some research under his belt, but noted that he had not been gaining any clinical experience during this time! So the registrar who did not get a Fellowship continued to gain clinical experience and he was the one who got the Senior Registrar job when it came up! When I took on MRC Clinical Research Fellows myself I tried to ensure that these bright young men did continue to gain some clinical experience as well as learning research methods. But now a new problem arose. My consultant colleagues soon found how competent the young men were and tried to take them out of the laboratory at short notice when some crisis arose. I had to 'fight over their bodies'. My colleagues just could not understand that an experiment planned for that afternoon must take precedence over the need for a replacement doctor in the follow-up clinic. õ
The answer is for all concerned to devise a plan for clinical research that recognizes these problems and rewards the bright young doctors instead of penalising them. It takes time for them to get some research under their belts. These 'years out' must not be held against them. In the USA we suffer from the same linguistic disease: the systematic, tireless effort of medical bureaucrats to transform the profession into something menial. In my youth, the milkman delivered the milk, a small boy the morning newspaper: now we 'health care providers', among many other workers, will deliver medical care. Dr Walter's word-derivations expose some of the euphemisms and distortions of the health service's new vocabulary. He might have made an even stronger case in preferring the term 'patient' (Latin pati 'to suffer'; patiens 'bearing', 'suffering'; patientia 'patience', 'endurance', 'forbearance') to 'client' (Latin cliens 'a retainer', 'dependant' , 'vassal'). The Government's White Paper views 'patient' as demeaning, was denoting inequality between doctor and sufferer with the latter in the inferior position. Could any word carry a more down-putting connotation than 'dependant' ('hanging down', 'subordinate', 'subject to')? Social service workers in the USA used to call patients 'clients' but have largely abandoned 'clients' because it is the more humiliating.
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Dr Walters asks, 'do words matter?' Indeed they do. 
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We regret that due to a technical fault the diagram for Figure I on p 680 of the December issue of JRSM was not printed. It is now printed below.
Psychological Variables
Figure 1 Three dimensions of a comprehensive outcome assessment
